Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism

NCT01145859 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01145859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01145859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism
Lead sponsor
Bayer
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2010
Completion date
July 31, 2015
Enrollment
59 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

pediatrics, venous thrombosis